This report was recently updated on May 23 2023 with the latest and most recent
market numbers
Disposable Medical Devices and Medical Sensors Market Analysis - Forecasts to 2025 By Product (Biosensors, Image sensors, Accelerometer, Pressure sensors, Temperature sensors), By Placement Scenario (Strip sensor, Wearable sensor, Implantable sensor, Invasive sensor, Ingestible sensor), By Application (Patient Monitoring, Diagnostics, Therapeutics), By Region (North America, Europe, Asia Pacific, Middle East & Africa, Central & South America), End-use Landscape, Vendor Landscape, & Competitor Analysis | Business Intelligence Report - Global Market Estimates
Market Insights
The disposable medical devices and medical sensors market is anticipated to grow at CAGR of 10% from 2017 to 2025. Market growth can be attributed to the increased occurrences of diabetes and infectious & chronic ailments over the globe.
The other factors which are anticipated to drive the market for disposable medical devices are sustained innovations and technological advancements in the point of care diagnosis and monitoring outside hospitals.
At the same time, the increased need for monitoring conditions of the remote patient and next generation disposable medical sensors such as painless diabetes screens, wearable wrist watches are few incentives driving the demand for disposable medical devices.
Extensive number of administrative endorsements for bio degradable devices is also expected to positively influence the global disposable medical devices and medical sensors market. However absence of adequate repayment options for novel technologies and stringent administrative procedures are major factors that may constrain the worldwide disposable medical device sensors growth over the coming years.
Product Insights
Biosensors market held the largest global share in 2016 attributed to their increased consumption in drug development processes. The image sensors segment is projected to grow at a very high CAGR over the forecast period. Growth in this segment is due to the increased demand for CMOS image sensors and emerging endoscopy products such as camera pills and disposable endoscopes.
The growth of strip sensors is mainly due to their rising usage in disease detection and glucose monitoring tests. However, ingestible sensors market is projected to grow at the fastest rate over the estimated period due to increasing demand for capsule endoscopes and smart pills.
Placement Insights
By placement, the industry is divided into wearable, implantable, ingestible, invasive, and strip sensors. The growth of strip sensors segment is driven by the widespread acceptance in diagnostic applications, cost effectiveness, convenience, non-infectious nature, and faster results.
Application Insights
The therapeutic devices segment includes insulin pump, dialysis device, cardiac therapy devices, and cardiac catheter sensors which helps the physicians to get access to better computerised and quick reports. The diagnostic testing devices unit is further segmented into HIV test kits, drug & alcohol test kits, and blood glucose test strips.
In order to distinguish between the diagnostic markets landscape, an overall understanding of the inter-segment relationships and intra-segment breakdowns is necessary; this is especially important when segmentation across diagnostic companies is not standardized.
Patient monitoring devices is expected to grow at a fast pace. The respiratory monitors segment is also anticipated to grow rapidly over the forecast period. This growth can be attributed to the increased occurrences of obstructive sleep apnea and the rising alternate uses of capnographs.
The remote patient monitoring (RPM) devices segment has also been doing exceptionally well, with the help of government regulations to control the rising healthcare costs. The technological advancements and launch of new products are contributing to the growth of RPM devices.
End-Users Insights
Healthcare centres and laboratories dominate the market as most of the indicative tests are performed in-house. The hospitals, academic & analytic research facilities segment held the maximum share in 2016 and are anticipated to dominate the market over the next few years. The demand for healing centres or demonstrative research centres is developing as they provide a proper lab setting, where information obtained from patient samples is used for investigation and development of personalized medications.
Regional Insights
North America was the largest market for these therapeutic instruments owing to the developed healthcare industry, raising consumer awareness, government activities, and new launch and advancements. Implementation of hygiene and cleanliness measures by virtue of the stringent regulatory system is expected to boost the overall market consumption in Europe.
Rising economies in Asia-Pacific mostly India, China, South Korea, and Japan are anticipated to demonstrate a steady growth rate in medical product usage by virtue of creating healthcare facilities which in turn is supposed to bring higher market demand over the forecast period.
India and China are anticipated to offer remarkable opportunities on account of healthcare infrastructure improvement and increasing number of private hospitals. In Africa, industry is projected to grow at a lower rate due to the absence of healthcare sector advancement initiatives and expensive medical services. Central and South America is foreseen to rise at the steady rate primarily on account of high cost along with minimum awareness by the territorial government.
End-Use Landscape
The end-use landscape entails a list of current and prospective consumers prevailing across the regions. This section provides company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase disposable medical devices and medical sensors over the coming years. Few of the consumers are Stanley Healthcare, Gerson Institute, and StemGenn Therapeutics Hospital.
Competitor Analysis
The major organizations operating in this market concentrate on product development for maintaining competitive advantage. In May, 2014 Honeywell International, Inc. launched Nano power Anisotropic Magnetoresistive Sensor ICs which gives high level of magnetic sensitivity to be used in healthcare applications such as medication dispensing cabinets and infusion pumps.
Siemens being a global healthcare company, are continuously developing the product portfolio base, from medical imaging and laboratory diagnostics, to advanced healthcare services along with other technological advancements for therapeutic and molecular diagnostics.
1 RESEARCH METHODOLOGY
1.1 DESK RESEARCH
1.2 PRIMARY RESEARCH
1.3 ANALYSIS AND OUTPUT
1.4 FINAL OUTPUT FROM DESK AND PRIMARY RESEARCH
2 ECOSYSTEM OVERVIEW
3 TECHNOLOGICAL TRENDS IN DISPOSABLE MEDICAL DEVICES AND MEDICAL SENSORS MARKET
4 DEMAND AND SUPPLY MATRIX
4.1 INTRODUCTION
4.2 DEMAND SIDE ANALYSIS
4.2.1 MARKET DRIVERS
4.2.2MARKET RESTRAINTS
4.2.3 MARKET OPPORTUNITIES
4.2.4 MARKET CHALLENGES
4.3 SUPPLY SIDE ANALYSIS
4.3.1 FUTURE SCENARIO (CAGR% VS. COUNTRY)
4.3.2 MAPPING KEY DISPOSABLE MEDICAL DEVICES AND MEDICAL SENSOR MANUFACTURERS
4.3.3 PORTER’S FIVE FORCES ANALYSIS
4.3.3.1 Threat of new entrants
4.3.3.2 Threat of substitutes
4.3.3.3 Bargaining power of buyers
4.3.3.4 Bargaining power of suppliers
4.3.3.5 Intensity of competitive rivalry
4.3.4 TREND ANALYSIS
4.4 PESTLE ANALYSIS
4.5 IMPACT ANALYSIS
4.6 PATENT LISTING
4.7 BEHAVIOURAL ANALYSIS
4.7.1 KEY MACRO INDICATORS
4.7.2 KEY MICRO INDICATORS
5 REGULATORY FRAMEWORK
6 DISPOSABLE MEDICAL DEVICES AND MEDICAL SENSORS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 BIOSENSOR
6.3 IMAGE SENSOR
6.4 ACCELEROMETER
6.5 PRESSURE SENSORS
6.6 TEMPERATURE SENSORS
7 DISPOSABLE MEDICAL DEVICES AND MEDICAL SENSORS MARKET, BY PLACEMENT SCENARIO
7.1 INTRODUCTION
7.2 STRIP SENSORS
7.3 WEARABLE SENSORS
7.4 IMPLANTABLE SENSORS
7.5 INVASIVE SENSORS
7.6 INGESTIBLE SENSORS
8 DISPOSABLE MEDICAL DEVICES AND MEDICAL SENSORS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 PATIENT MONITORING
8.3 DIAGNOSTICS
8.4 THERAPEUTICS
9 DISPOSABLE MEDICAL DEVICES AND MEDICAL SENSORS MARKET, BY END-USE
9.1 INTRODUCTION
9.2 HOSPITAL
9.3 LABORATORIES
9.4 OTHERS
10 DISPOSABLE MEDICAL DEVICES AND MEDICAL SENSORS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 BY PRODUCT
10.2.2 BY PLACEMENT SCENARIO
10.2.3 BY APPLICATION
10.2.4 BY END-USE
10.2.5 BY COUNTRY
10.2.5.1 U.S.
10.2.5.1.1 By product
10.2.5.1.2 By placement scenario
10.2.5.1.3 By application.
10.2.5.1.4 By end-use
10.2.5.2 CANADA
10.2.5.2.1 By product
10.2.5.2.2 By placement scenario
10.2.5.2.3 By application.
10.2.5.2.4 By end-use
10.2.5.3 MEXICO
10.2.5.3.1 By product
10.2.5.3.2 By placement scenario
10.2.5.3.3 By application.
10.2.5.3.4 By end-use
10.3 EUROPE
10.3.1 BY PRODUCT
10.3.2 BY PLACEMENT SCENARIO
10.3.3 BY APPLICATION
10.3.4 BY END-USE
10.3.5 BY COUNTRY
10.3.5.1 GERMANY
10.3.5.1.1 By product
10.3.5.1.2 By placement scenario
10.3.5.1.3 By application.
10.3.5.1.4 By end-use
10.3.5.2 UK
10.3.5.2.1 By product
10.3.5.2.2 By placement scenario
10.3.5.2.3 By application.
10.3.5.2.4 By end-use
10.3.5.3 FRANCE
10.3.5.3.1 By product
10.3.5.3.2 By placement scenario
10.3.5.3.3 By application.
10.3.5.3.4 By end-use
10.3.5.4 ITALY
10.3.5.4.1 By product
10.3.5.4.2 By placement scenario
10.3.5.4.3 By application.
10.3.5.4.4 By end-use
10.3.5.5 SPAIN
10.3.5.5.1 By product
10.3.5.5.2 By placement scenario
10.3.5.5.3 By application.
10.3.5.5.4 By end-use
10.4 ASIA PACIFIC
10.4.1 BY PRODUCT
10.4.2 BY PLACEMENT SCENARIO
10.4.3 BY APPLICATION
10.4.4 BY END-USE
10.4.5 BY COUNTRY
10.4.5.1 CHINA
10.4.5.1.1 By product
10.4.5.1.2 By placement scenario
10.4.5.1.3 By application.
10.4.5.1.4 By end-use
10.4.5.2 INDIA
10.4.5.2.1 By product
10.4.5.2.2 By placement scenario
10.4.5.2.3 By application.
10.4.5.2.4 By end-use
10.4.5.3 JAPAN
10.4.5.3.1 By product
10.4.5.3.2 By placement scenario
10.4.5.3.3 By application.
10.4.5.3.4 By end-use
10.5 CENTRAL & SOUTH AMERICA
10.5.1 BY PRODUCT
10.5.2 BY PLACEMENT SCENARIO
10.5.3 BY APPLICATION
10.5.4 BY END-USE
10.5.5 BY COUNTRY
10.5.5.1 BRAZIL
10.5.5.1.1 By product
10.5.5.1.2 By placement scenario
10.5.5.1.3 By application.
10.5.5.1.4 By end-use
10.6 MIDDLE EAST & AFRICA
10.6.1 BY PRODUCT
10.6.2 BY PLACEMENT SCENARIO
10.6.3 BY APPLICATION
10.6.4 BY END-USE
10.6.5 BY COUNTRY
10.6.5.1 SAUDI-ARABIA
10.6.5.1.1 By product
10.6.5.1.2 By placement scenario
10.6.5.1.3 By application.
10.6.5.1.4 By end-use
10.6.5.2 SOUTH-AFRICA
10.6.5.2.1 By product
10.6.5.2.2 By placement scenario
10.6.5.2.3 By application.
10.6.5.2.4 By end-use
11 END-USE LANDSCAPE (CONSUMER PROFILE)
11.1 NORTH AMERICA
11.2 EUROPE
11.3 ASIA-PACIFIC
11.4 CENTRAL & SOUTH AMERICA
11.5 MIDDLE EAST & AFRICA
12 VENDOR LANDSCAPE (SUPPLIERS/MANUFACTURERS/DISTRIBUTORS)
12.1 NORTH AMERICA
12.2 EUROPE
12.3 ASIA-PACIFIC
12.4 CENTRAL & SOUTH AMERICA
12.5 MIDDLE EAST & AFRICA
13 COMPANY PROFILE
13.1 MEDTRONIC PLC.
13.1.1 BUSINESS DESCRIPTION
13.1.2 FINANCIAL PERFORMANCE
13.1.3 SWOT ANALYSIS
13.1.4 PRODUCTS AND SERVICES OFFERED
13.1.5 STRATEGIC INITIATIVES
13.2 STMICROELECTRONICS N.V.
13.2.1 BUSINESS DESCRIPTION
13.2.2 FINANCIAL PERFORMANCE
13.2.3 SWOT ANALYSIS
13.2.4 PRODUCTS AND SERVICES OFFERED
13.2.5 STRATEGIC INITIATIVES
13.3 HONEYWELL INTERNATIONAL, INC.
13.3.1 BUSINESS DESCRIPTION
13.3.2 FINANCIAL PERFORMANCE
13.3.3 SWOT ANALYSIS
13.3.4 PRODUCTS AND SERVICES OFFERED
13.3.5 STRATEGIC INITIATIVES
13.4 TE CONNECTIVITY
13.4.1 BUSINESS DESCRIPTION
13.4.2 FINANCIAL PERFORMANCE
13.4.3 SWOT ANALYSIS
13.4.4 PRODUCTS AND SERVICES OFFERED
13.4.5 STRATEGIC INITIATIVES
13.5 SMITHS MEDICAL
13.5.1 BUSINESS DESCRIPTION
13.5.2 FINANCIAL PERFORMANCE
13.5.3 SWOT ANALYSIS
13.5.4 PRODUCTS AND SERVICES OFFERED
13.5.5 STRATEGIC INITIATIVES
13.6 GE HEALTHCARE
13.6.1 BUSINESS DESCRIPTION
13.6.2 FINANCIAL PERFORMANCE
13.6.3 SWOT ANALYSIS
13.6.4 PRODUCTS AND SERVICES OFFERED
13.6.5 STRATEGIC INITIATIVES
13.7 PHILIPS HEALTHCARE
13.7.1 BUSINESS DESCRIPTION
13.7.2 FINANCIAL PERFORMANCE
13.7.3 SWOT ANALYSIS
13.7.4 PRODUCTS AND SERVICES OFFERED
13.7.5 STRATEGIC INITIATIVES
13.8 FREESCALE SEMICONDUCTOR, INC.
13.8.1 BUSINESS DESCRIPTION
13.8.2 FINANCIAL PERFORMANCE
13.8.3 SWOT ANALYSIS
13.8.4 PRODUCTS AND SERVICES OFFERED
13.8.5 STRATEGIC INITIATIVES
13.9 ANALOG DEVICES, INC..
13.9.1 BUSINESS DESCRIPTION
13.9.2 FINANCIAL PERFORMANCE
13.9.3 SWOT ANALYSIS
13.9.4 PRODUCTS AND SERVICES OFFERED
13.9.5 STRATEGIC INITIATIVES
13.10 OMNIVISION TECHNOLOGIES INC.
13.10.1 BUSINESS DESCRIPTION
13.10.2 FINANCIAL PERFORMANCE
13.10.3 SWOT ANALYSIS
13.10.4 PRODUCTS AND SERVICES OFFERED
13.10.5 STRATEGIC INITIATIVES
13.11 ANALOG DEVICES
13.11.1 BUSINESS DESCRIPTION
13.11.2 FINANCIAL PERFORMANCE
13.11.3 SWOT ANALYSIS
13.11.4 PRODUCTS AND SERVICES OFFERED
13.11.5 STRATEGIC INITIATIVES
13.12 COVIDIEN
13.12.1 BUSINESS DESCRIPTION
13.12.2 FINANCIAL PERFORMANCE
13.12.3 SWOT ANALYSIS
13.12.4 PRODUCTS AND SERVICES OFFERED
13.12.5 STRATEGIC INITIATIVES
13.13 SMITHS MEDICAL
13.13.1 BUSINESS DESCRIPTION
13.13.2 FINANCIAL PERFORMANCE
13.13.3 SWOT ANALYSIS
13.13.4 PRODUCTS AND SERVICES OFFERED
13.13.5 STRATEGIC INITIATIVES
13.14 SENSIRION AG.
13.14.1 BUSINESS DESCRIPTION
13.14.2 FINANCIAL PERFORMANCE
13.14.3 SWOT ANALYSIS
13.14.4 PRODUCTS AND SERVICES OFFERED
13.14.5 STRATEGIC INITIATIVES
13.15 NXP SEMICONDUCTORS N.V
13.15.1 BUSINESS DESCRIPTION
13.15.2 FINANCIAL PERFORMANCE
13.15.3 SWOT ANALYSIS
13.15.4 PRODUCTS AND SERVICES OFFERED
13.15.5 STRATEGIC INITIATIVES
The global disposable medical devices and medical sensors market report has been studied from the year 2016 till 2025. However, the CAGR provided in the market study is from the year 2017 to 2025. The market research method involved three stages: Desk research, Primary survey research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the industry analysis; industry trends; market analysis; market trends; market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the disposable medical devices and medical sensors market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, VPs, CEOs, COOs, financial consultants, business consultants, strategy consultants, project management consultants, business management consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, demand forecasting, SWOT analysis of the company’s manufacturing disposable medical devices and medical sensors, and customer analytics.
A dedicated client engagement team for round the clock support in terms of requirement gathering, query handling, and any other support activity.
More than 50% of innovation comes from the voice of the customer through which our analysts find blindspots in your revenue decisions.
The best vision is actionable insights across high growth markets with GMEs disruptive research methodology.
Disruptive research that correlates markets, technologies, new use cases and companies.
80% of Fortune 2000 use GME for their growth strategies.
Get in-depth analysis of the COVID-19 impact on this study
Benchmarking the rapid strategy shifts of the Top 100 companies in this market space
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
